Methods and algorithm for selecting allogenic hematopoietic cell donor based on KIR and HLA genotypes

摘要

This disclosure is directed to a method for scoring and ranking candidate HLA-compatible unrelated hematopoietic cell donors (URD) for patients with AML or myelodysplastic syndrome. Candidate donors are scored based on KIR/HLA allele and genotype combinations. The method disclosed herein permitS ranking and selection of advantageous donors that predict improved clinical outcomes of hematopoietic stem cell transplantation.